{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:38:11Z","timestamp":1793299091443,"version":"4.5.0"},"reference-count":75,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Secondary hypertension (SH) is a form of high blood pressure caused by an identifiable underlying condition. Although, it accounts for a small fraction of the overall hypertensive population, detection and management of SH is of utmost importance, because SH phenotypes carry a high cardiovascular risk and can possibly be cured by timely treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Content<\/jats:title>\n                    <jats:p>This review focuses on the endocrine causes of SH, such as primary aldosteronism, Cushing syndrome, thyroid disease, pheochromocytoma and paraganglioma, acromegaly, and rare monogenic forms. It discusses current biomarkers, analytical methods, and diagnostic strategies, highlighting advantages and limitations of each approach. It also explores the emerging -omics technologies that can provide a comprehensive and multidimensional assessment of SH and its underlying mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Endocrine SH is a heterogeneous and complex condition that requires proper screening and confirmatory tests to avoid diagnostic delays and improve patient outcomes. Careful biomarker interpretation is essential due to potential interferences, variability, and method-dependent differences. Liquid chromatography\u2013tandem mass spectrometry is a superior method for measuring low-concentration hormones and metabolites involved in SH, but it requires expertise. Omics approaches have great potential to identify novel biomarkers, pathways, and targets for SH diagnosis and treatment, especially considering its multifactorial nature.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/clinchem\/hvae022","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T10:22:46Z","timestamp":1709806966000},"page":"709-726","source":"Crossref","is-referenced-by-count":8,"title":["Laboratory Testing for Endocrine Hypertension: Current and Future Perspectives"],"prefix":"10.1093","volume":"70","author":[{"given":"Louisiane","family":"Courcelles","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Cliniques Universitaires St-Luc and Universit\u00e9 Catholique de Louvain , Brussels , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Stoenoiu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Rheumatology, Cliniques Universitaires Saint-Luc, Institut de Recherche Exp\u00e9rimentale et Clinique, Universit\u00e9 Catholique de Louvain , Brussels , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Haufroid","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Cliniques Universitaires St-Luc and Universit\u00e9 Catholique de Louvain , Brussels , Belgium"},{"name":"Louvain centre for Toxicology and Applied Pharmacology (LTAP), Institut de Recherche Exp\u00e9rimentale et Clinique, Universit\u00e9 Catholique de Louvain , Brussels , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilucy","family":"Lopez-Sublet","sequence":"additional","affiliation":[{"name":"AP-HP, H\u00f4pital Avicenne, Centre d'Excellence Europ\u00e9en en Hypertension Art\u00e9rielle, Service de M\u00e9decine Interne , Paris , France"},{"name":"INSERM UMR 942 MASCOT, Paris 13-Universit\u00e9 Paris Nord , Bobigny , France"},{"name":"FCRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), CHRU de Nancy - H\u00f4pitaux de Brabois, Vandoeuvre-l\u00e8s-Nancy , France"},{"name":"Division of Cardiology, Cliniques Universitaires Saint-Luc, Universit\u00e9 Catholique de Louvain , Brussels , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidvine","family":"Boland","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Cliniques Universitaires St-Luc and Universit\u00e9 Catholique de Louvain , Brussels , Belgium"},{"name":"Louvain centre for Toxicology and Applied Pharmacology (LTAP), Institut de Recherche Exp\u00e9rimentale et Clinique, Universit\u00e9 Catholique de Louvain , Brussels , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loris","family":"Wauthier","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Cliniques Universitaires St-Luc and Universit\u00e9 Catholique de Louvain , Brussels , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Beauloye","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Cliniques Universitaires Saint-Luc, Universit\u00e9 Catholique de Louvain , Brussels , Belgium"},{"name":"Pole of Cardiovascular Research, Institut de Recherche Exp\u00e9rimentale et Clinique, Universit\u00e9 Catholique de Louvain , Brussels , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Maiter","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Nutrition, Cliniques Universitaires St-Luc and Universit\u00e9 Catholique de Louvain , Brussels , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Januszewicz","sequence":"additional","affiliation":[{"name":"Department of Hypertension, National Institute of Cardiology , Warsaw , Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4818-211X","authenticated-orcid":false,"given":"Reinhold","family":"Kreutz","sequence":"additional","affiliation":[{"name":"Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Institute of Clinical Pharmacology and Toxicology , Charit\u00e9platz 1, 10117 Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Persu","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Cliniques Universitaires Saint-Luc, Universit\u00e9 Catholique de Louvain , Brussels , Belgium"},{"name":"Pole of Cardiovascular Research, Institut de Recherche Exp\u00e9rimentale et Clinique, Universit\u00e9 Catholique de Louvain , Brussels , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Gruson","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Cliniques Universitaires St-Luc and Universit\u00e9 Catholique de Louvain , Brussels , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,14]]},"reference":[{"key":"2024050123510147500_hvae022-B1","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH)","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"key":"2024050123510147500_hvae022-B2","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","author":"NCD Risk Factor Collaboration","year":"2021","journal-title":"Lancet"},{"key":"2024050123510147500_hvae022-B3","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"2024050123510147500_hvae022-B4","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2024050123510147500_hvae022-B5","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/jama.2023.11305","article-title":"Cushing syndrome: a review","volume":"330","author":"Reincke","year":"2023","journal-title":"JAMA"},{"key":"2024050123510147500_hvae022-B6","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2024050123510147500_hvae022-B7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7326\/M15-0483","article-title":"Screening for thyroid dysfunction: U.S. preventive services task force recommendation statement","volume":"162","author":"LeFevre","year":"2015","journal-title":"Ann Intern Med"},{"key":"2024050123510147500_hvae022-B8","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s12094-021-02622-9","article-title":"Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas","volume":"23","author":"Garcia-Carbonero","year":"2021","journal-title":"Clin Transl Oncol"},{"key":"2024050123510147500_hvae022-B9","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S2213-8587(22)00244-3","article-title":"Acromegaly: pathogenesis, diagnosis, and management","volume":"10","author":"Fleseriu","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2024050123510147500_hvae022-B10","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: an endocrine society clinical practice guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2024050123510147500_hvae022-B11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1055\/a-1134-4980","article-title":"Hypokalemia and the prevalence of primary aldosteronism","volume":"52","author":"Gruber","year":"2020","journal-title":"Horm Metab Res"},{"key":"2024050123510147500_hvae022-B12","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1373\/clinchem.2016.255737","article-title":"Overestimation of aldosterone by immunoassay in renal impairment","volume":"62","author":"Lam","year":"2016","journal-title":"Clin Chem"},{"key":"2024050123510147500_hvae022-B13","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1515\/cclm-2022-0375","article-title":"Stability of direct renin concentration and plasma renin activity in EDTA whole blood and plasma at ambient and refrigerated temperatures from 0 to 72 hours","volume":"60","author":"Hepburn","year":"2022","journal-title":"Clin Chem Lab Med"},{"key":"2024050123510147500_hvae022-B14","doi-asserted-by":"crossref","first-page":"e24738","DOI":"10.1002\/jcla.24738","article-title":"The spectrum of plasma renin activity and hypertension diseases: utility, outlook, and suggestions","volume":"36","author":"Liu","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"2024050123510147500_hvae022-B15","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1039\/D2AY01646J","article-title":"Development of a designed comparison method based on isotope dilution liquid chromatography-tandem mass spectrometry for determining plasma renin activity and its clinical assessment of renin activity stability in plasma","volume":"15","author":"Liu","year":"2023","journal-title":"Anal Methods"},{"key":"2024050123510147500_hvae022-B16","doi-asserted-by":"crossref","first-page":"684111","DOI":"10.3389\/fphar.2021.684111","article-title":"The effect of antihypertensive medications on testing for primary aldosteronism","volume":"12","author":"J\u0119drusik","year":"2021","journal-title":"Front Pharmacol"},{"key":"2024050123510147500_hvae022-B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2023.05.021","article-title":"How should anti-hypertensive medications be adjusted before screening for primary aldosteronism?","author":"Lu","journal-title":"J Formos Med Assoc"},{"key":"2024050123510147500_hvae022-B18","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S2213-8587(21)00210-2","article-title":"Diagnosis and treatment of primary aldosteronism","volume":"9","author":"Reincke","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2024050123510147500_hvae022-B19","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1210\/jc.2016-3851","article-title":"Effect of combined hormonal replacement therapy on the aldosterone\/renin ratio in postmenopausal women","volume":"102","author":"Ahmed","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2024050123510147500_hvae022-B20","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1055\/s-0031-1295460","article-title":"Factors affecting the aldosterone\/renin ratio","volume":"44","author":"Stowasser","year":"2012","journal-title":"Horm Metab Res"},{"key":"2024050123510147500_hvae022-B21","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1515\/cclm-2022-1190","article-title":"Standard \u221220\u00b0C freezer storage protocols may cause substantial plasma renin cryoactivation","volume":"61","author":"Bonnitcha","year":"2023","journal-title":"Clin Chem Lab Med"},{"key":"2024050123510147500_hvae022-B22","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1210\/clinem\/dgab348","article-title":"Performance of the aldosterone to renin ratio as a screening test for primary aldosteronism","volume":"106","author":"Hung","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2024050123510147500_hvae022-B23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1515\/cclm-2019-0706","article-title":"Comparison of three different chemiluminescence assays and a rapid liquid chromatography tandem mass spectrometry method for measuring serum aldosterone","volume":"58","author":"Yin","year":"2019","journal-title":"Clin Chem Lab Med"},{"key":"2024050123510147500_hvae022-B24","doi-asserted-by":"crossref","first-page":"bvac049","DOI":"10.1210\/jendso\/bvac049","article-title":"Recalibrating interpretations of aldosterone assays across the physiologic range: immunoassay and liquid chromatography\u2013tandem mass spectrometry measurements under multiple controlled conditions","volume":"6","author":"Brown","year":"2022","journal-title":"J Endocr Soc"},{"key":"2024050123510147500_hvae022-B25","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1210\/clinem\/dgaa606","article-title":"Evolution of the primary aldosteronism syndrome: updating the approach","volume":"105","author":"Vaidya","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2024050123510147500_hvae022-B26","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/HYPERTENSIONAHA.120.16429","article-title":"Intraindividual variability of aldosterone concentrations in primary aldosteronism: implications for case detection","volume":"77","author":"Yozamp","year":"2021","journal-title":"Hypertension"},{"key":"2024050123510147500_hvae022-B27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12020-022-03084-x","article-title":"Performance of the aldosterone-to-renin ratio as a screening test for primary aldosteronism in primary care","volume":"77","author":"Ariens","year":"2022","journal-title":"Endocrine"},{"key":"2024050123510147500_hvae022-B28","doi-asserted-by":"crossref","first-page":"8647026","DOI":"10.1155\/2018\/8647026","article-title":"Age-related cutoffs of plasma aldosterone\/renin concentration for primary aldosteronism screening","volume":"2018","author":"Ma","year":"2018","journal-title":"Int J Endocrinol"},{"key":"2024050123510147500_hvae022-B29","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1097\/HJH.0000000000002510","article-title":"Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the working group on Endocrine Hypertension of The European Society of Hypertension","volume":"38","author":"Mulatero","year":"2020","journal-title":"J Hypertens"},{"key":"2024050123510147500_hvae022-B30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s42155-021-00220-y","article-title":"Adrenal vein sampling: technique and protocol, a systematic review","volume":"4","author":"Quencer","year":"2021","journal-title":"CVIR Endovasc"},{"key":"2024050123510147500_hvae022-B31","doi-asserted-by":"crossref","first-page":"R205","DOI":"10.1530\/EJE-16-0946","article-title":"DIAGNOSIS OF ENDOCRINE DISEASE: differentiation of pathologic\/neoplastic hypercortisolism (Cushings syndrome) from physiologic\/non-neoplastic hypercortisolism (formerly known as pseudo-Cushings syndrome)","volume":"176","author":"Findling","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"2024050123510147500_hvae022-B32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s12020-018-1805-z","article-title":"Is GH nadir during OGTT a reliable test for diagnosis of acromegaly in patients with abnormal glucose metabolism?","volume":"64","author":"Dobri","year":"2019","journal-title":"Endocrine"},{"key":"2024050123510147500_hvae022-B33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.21037\/pm-21-48","article-title":"A narrative review of hyporeninemic hypertension\u2014an indicator for monogenic forms of hypertension","volume":"5","author":"Mashmoushi","year":"2022","journal-title":"Pediatr Med"},{"key":"2024050123510147500_hvae022-B34","doi-asserted-by":"crossref","first-page":"543309","DOI":"10.3389\/fped.2020.543309","article-title":"Overview of monogenic forms of hypertension combined with hypokalemia","volume":"8","author":"Lu","year":"2020","journal-title":"Front Pediatr"},{"key":"2024050123510147500_hvae022-B35","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1210\/clinem\/dgaa105","article-title":"Accuracy of laboratory tests for the diagnosis of Cushing syndrome","volume":"105","author":"Galm","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2024050123510147500_hvae022-B36","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1373\/clinchem.2003.029934","article-title":"Diminished urinary free cortisol excretion in patients with moderate and severe renal impairment","volume":"50","author":"Chan","year":"2004","journal-title":"Clin Chem"},{"key":"2024050123510147500_hvae022-B37","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/cen.14262","article-title":"Dietary sodium intake and cortisol measurements","volume":"93","author":"Chen","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024050123510147500_hvae022-B38","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1055\/s-0031-1286297","article-title":"Measurement of urinary free cortisol by current immunoassays: need for sex-dependent reference ranges to define hypercortisolism","volume":"43","author":"Deutschbein","year":"2011","journal-title":"Horm Metab Res"},{"key":"2024050123510147500_hvae022-B39","doi-asserted-by":"crossref","first-page":"101519","DOI":"10.1016\/j.beem.2021.101519","article-title":"Biochemical diagnosis of Cushing\u2019s disease: screening and confirmatory testing","volume":"35","author":"Petersenn","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2024050123510147500_hvae022-B40","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/cen.13023","article-title":"Dynamics of salivary cortisol in chronic kidney disease patients at stages 1 through 4","volume":"85","author":"Cardoso","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024050123510147500_hvae022-B41","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1515\/cclm-2016-1100","article-title":"Influence of age, gender and body mass index on late-night salivary cortisol in healthy adults","volume":"55","author":"Coelli","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"2024050123510147500_hvae022-B42","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3343\/alm.2020.40.4.285","article-title":"Cortisol measurements in Cushing\u2019s syndrome: immunoassay or mass spectrometry?","volume":"40","author":"Casals","year":"2020","journal-title":"Ann Lab Med"},{"key":"2024050123510147500_hvae022-B43","doi-asserted-by":"crossref","first-page":"658429","DOI":"10.3389\/fendo.2021.658429","article-title":"Cyclic Cushing\u2019s syndrome\u2014a diagnostic challenge","volume":"12","author":"\u015awi\u0105tkowska-Stodulska","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2024050123510147500_hvae022-B44","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3343\/alm.2021.41.6.521","article-title":"Second-line tests in the diagnosis of adrenocorticotropic hormone-dependent hypercortisolism","volume":"41","author":"Pinelli","year":"2021","journal-title":"Ann Lab Med"},{"key":"2024050123510147500_hvae022-B45","doi-asserted-by":"crossref","first-page":"dgaa409","DOI":"10.1210\/clinem\/dgaa409","article-title":"Non-invasive diagnostic strategy in ACTH-dependent cushing\u2019s syndrome","volume":"105","author":"Frete","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2024050123510147500_hvae022-B46","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s11102-022-01253-9","article-title":"Genetics of Cushing\u2019s disease: from the lab to clinical practice","volume":"25","author":"Theodoropoulou","year":"2022","journal-title":"Pituitary"},{"key":"2024050123510147500_hvae022-B47","first-page":"1","volume-title":"Endocrinology and systemic diseases","author":"Carbone","year":"2019"},{"key":"2024050123510147500_hvae022-B48","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/HJH.0000000000002438","article-title":"Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the working group on Endocrine Hypertension of the European Society of Hypertension","volume":"38","author":"Lenders","year":"2020","journal-title":"J Hypertens"},{"key":"2024050123510147500_hvae022-B49","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1373\/clinchem.2018.291369","article-title":"Biochemical diagnosis of chromaffin cell tumors in patients at high and low risk of disease: plasma versus urinary free or deconjugated O-methylated catecholamine metabolites","volume":"64","author":"Eisenhofer","year":"2018","journal-title":"Clin Chem"},{"key":"2024050123510147500_hvae022-B50","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cca.2018.12.019","article-title":"Reference intervals for LC-MS\/MS measurements of plasma free, urinary free and urinary acid-hydrolyzed deconjugated normetanephrine, metanephrine and methoxytyramine","volume":"490","author":"Eisenhofer","year":"2019","journal-title":"Clin Chim Acta"},{"key":"2024050123510147500_hvae022-B51","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1210\/jc.2009-0303","article-title":"Dietary influences on plasma and urinary metanephrines: implications for diagnosis of catecholamine-producing tumors","volume":"94","author":"de Jong","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2024050123510147500_hvae022-B52","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1210\/endrev\/bnab019","article-title":"Personalized management of pheochromocytoma and paraganglioma","volume":"43","author":"N\u00f6lting","year":"2022","journal-title":"Endocr Rev"},{"key":"2024050123510147500_hvae022-B53","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3390\/cancers11040586","article-title":"Chromogranin A in the laboratory diagnosis of pheochromocytoma and paraganglioma","volume":"11","author":"B\u00edlek","year":"2019","journal-title":"Cancers (Basel)"},{"key":"2024050123510147500_hvae022-B54","doi-asserted-by":"crossref","first-page":"L57","DOI":"10.1530\/ERC-17-0061","article-title":"KIF1B and NF1 are the most frequently mutated genes in paraganglioma and pheochromocytoma tumors","volume":"24","author":"Evenepoel","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"2024050123510147500_hvae022-B55","doi-asserted-by":"crossref","first-page":"138573","DOI":"10.1155\/2015\/138573","article-title":"Profiling of somatic mutations in phaeochromocytoma and paraganglioma by targeted next generation sequencing analysis","volume":"2015","author":"Luchetti","year":"2015","journal-title":"Int J Endocrinol"},{"key":"2024050123510147500_hvae022-B56","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3390\/jcm10051147","article-title":"The biochemical diagnosis of acromegaly","volume":"10","author":"Akirov","year":"2021","journal-title":"J Clin Med"},{"key":"2024050123510147500_hvae022-B57","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/ajh\/hpaa022","article-title":"Genomic determinants of hypertension with a focus on metabolomics and the gut microbiome","volume":"33","author":"Louca","year":"2020","journal-title":"Am J Hypertens"},{"key":"2024050123510147500_hvae022-B58","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41440-022-00885-5","article-title":"Application of omics in hypertension and resistant hypertension","volume":"45","author":"Guo","year":"2022","journal-title":"Hypertens Res"},{"key":"2024050123510147500_hvae022-B59","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/HYPERTENSIONAHA.117.09458","article-title":"Transcriptome-wide analysis identifies novel associations with blood pressure","volume":"70","author":"Zeller","year":"2017","journal-title":"Hypertension"},{"key":"2024050123510147500_hvae022-B60","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1210\/jc.2017-01314","article-title":"Expression of contactin 4 is associated with malignant behavior in pheochromocytomas and paragangliomas","volume":"103","author":"Evenepoel","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2024050123510147500_hvae022-B61","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1515\/cclm-2022-0470","article-title":"Integration of artificial intelligence and plasma steroidomics with laboratory information management systems: application to primary aldosteronism","volume":"60","author":"Constantinescu","year":"2022","journal-title":"Clin Chem Lab Med"},{"key":"2024050123510147500_hvae022-B62","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1373\/clinchem.2018.292201","article-title":"Using machine learning to aid the interpretation of urine steroid profiles","volume":"64","author":"Wilkes","year":"2018","journal-title":"Clin Chem"},{"key":"2024050123510147500_hvae022-B63","doi-asserted-by":"crossref","first-page":"e2016209","DOI":"10.1001\/jamanetworkopen.2020.16209","article-title":"Use of steroid profiling combined with machine learning for identification and subtype classification in primary aldosteronism","volume":"3","author":"Eisenhofer","year":"2020","journal-title":"JAMA Network Open"},{"key":"2024050123510147500_hvae022-B64","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/clinchem\/hvac191","article-title":"In situ metabolomics of cortisol-producing adenomas","volume":"69","author":"Murakami","year":"2023","journal-title":"Clin Chem"},{"key":"2024050123510147500_hvae022-B65","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1373\/clinchem.2019.306043","article-title":"Prognostic relevance of steroid sulfation in adrenocortical carcinoma revealed by molecular phenotyping using high-resolution mass spectrometry imaging","volume":"65","author":"Sun","year":"2019","journal-title":"Clin Chem"},{"key":"2024050123510147500_hvae022-B66","doi-asserted-by":"crossref","first-page":"e130356","DOI":"10.1172\/jci.insight.130356","article-title":"In situ metabolomics of aldosterone-producing adenomas","volume":"4","author":"Murakami","year":"2019","journal-title":"JCI insight"},{"key":"2024050123510147500_hvae022-B67","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1530\/EJE-20-1407","article-title":"Mass spectrometry imaging identifies metabolic patterns associated with malignant potential in pheochromocytoma and paraganglioma","volume":"185","author":"Murakami","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"2024050123510147500_hvae022-B68","doi-asserted-by":"crossref","first-page":"e551","DOI":"10.1016\/S2589-7500(23)00094-8","article-title":"Prediction of metastatic pheochromocytoma and paraganglioma: a machine learning modelling study using data from a cross-sectional cohort","volume":"5","author":"Pamporaki","year":"2023","journal-title":"Lancet Digit Health"},{"key":"2024050123510147500_hvae022-B69","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/clinchem\/hvaa001","article-title":"Measurement of equilibrium angiotensin II in the diagnosis of primary aldosteronism","volume":"66","author":"Guo","year":"2020","journal-title":"Clin Chem"},{"key":"2024050123510147500_hvae022-B70","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/00045632211008923","article-title":"An LC-MS\/MS assay for analysis of equilibrium angiotensin II in human serum","volume":"58","author":"Bernstone","year":"2021","journal-title":"Ann Clin Biochem"},{"key":"2024050123510147500_hvae022-B71","doi-asserted-by":"crossref","first-page":"970","DOI":"10.21037\/atm-22-3901","article-title":"Development and validation of a decision tree classification model for the essential hypertension based on serum protein biomarkers","volume":"10","author":"Han","year":"2022","journal-title":"Ann Transl Med"},{"key":"2024050123510147500_hvae022-B72","doi-asserted-by":"crossref","first-page":"e2200444","DOI":"10.1002\/pmic.202200444","article-title":"Identifying a urinary peptidomics profile for hypertension in young adults: the African-PREDICT study: urinary peptidomics and hypertension: urinary peptidomics and hypertension","volume":"23","author":"De Beer","year":"2023","journal-title":"Proteomics"},{"key":"2024050123510147500_hvae022-B73","doi-asserted-by":"crossref","first-page":"1096441","DOI":"10.3389\/fendo.2023.1096441","article-title":"Proteomic analysis of urinary extracellular vesicles highlights specific signatures for patients with primary aldosteronism","volume":"14","author":"Bertolone","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2024050123510147500_hvae022-B74","doi-asserted-by":"crossref","first-page":"104276","DOI":"10.1016\/j.ebiom.2022.104276","article-title":"Machine learning for classification of hypertension subtypes using multi-omics: a multi-centre, retrospective, data-driven study","volume":"84","author":"Reel","year":"2022","journal-title":"EBioMedicine"},{"key":"2024050123510147500_hvae022-B75"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/clinchem\/article-pdf\/70\/5\/709\/57368524\/hvae022.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/clinchem\/article-pdf\/70\/5\/709\/57368524\/hvae022.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T19:51:41Z","timestamp":1714593101000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/70\/5\/709\/7628898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,14]]},"references-count":75,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,3,14]]},"published-print":{"date-parts":[[2024,5,2]]}},"URL":"https:\/\/doi.org\/10.1093\/clinchem\/hvae022","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,5]]},"published":{"date-parts":[[2024,3,14]]}}}